Study title:
Walker-R-W, Rosenblum-M-K. Memorial Sloan-Kettering Cancer Cnt., 1275 York Avenue, New York, NY 10021, United States.
Childhood medulloblastoma.
Revue Neurologique {REV-NEUROL}, 1992, Vol/Iss/Pg. 148/6-7 (467-476), ISSN: 0035-3787.Walker-R-W, Rosenblum-M-K. Memorial Sloan-Kettering Cancer Cnt., 1275 York Avenue, New York, NY 10021, United States.
Childhood medulloblastoma.
Revue Neurologique {REV-NEUROL}, 1992, Vol/Iss/Pg. 148/6-7 (467-476), ISSN: 0035-3787.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|